Pneumonitis in Patients Treated With Anti-Programmed Death-1/Programmed Death Ligand 1 Therapy (vol 35, pg 709, 2017)

被引：2
|
作者：
Naidoo
Long, Georgina
Hellmann, Matthew
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷 / 22期
关键词：
D O I：
10.1200/JCO.2017.74.5042
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2590 / 2590
页数：1
相关论文
共 50 条
  • [41] Impact of response patterns for patients with advanced acral melanoma treated with anti-programmed death-1 monotherapy
    Zhou, Li
    Shao, Lizhi
    Gao, Shunyu
    Cui, Chuanliang
    Chi, Zhihong
    Sheng, Xinan
    Tang, Bixia
    Mao, Lili
    Lian, Bin
    Yan, Xieqiao
    Wang, Xuan
    Bai, Xue
    Li, Siming
    Guo, Jun
    Si, Lu
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 188 (01) : 112 - 121
  • [42] Sick sinus syndrome associated with anti-programmed cell death-1
    Hsu, Chien-Yi
    Su, Yu-Wen
    Chen, San-Chi
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2018, 6
  • [43] Interaction of Programmed Death-1 and Programmed Death-1 Ligand-1 Contributes to Testicular Immune Privilege
    Cheng, Xuyang
    Dai, Hehua
    Wan, Ni
    Moore, Yolonda
    Vankayalapati, Ramakrishna
    Dai, Zhenhua
    TRANSPLANTATION, 2009, 87 (12) : 1778 - 1786
  • [44] Programmed death-1/programmed death-1 ligand axis as a therapeutic target in oncology: current insights
    Schalper, Kurt A.
    Venur, Vyshak Alva
    Velcheti, Vamsidhar
    JOURNAL OF RECEPTOR LIGAND AND CHANNEL RESEARCH, 2015, 8 : 1 - 7
  • [45] Symptom Clusters and Social Support in Patients With Lung Cancer Undergoing Anti-Programmed Death 1/Programmed Death Ligand 1 Immunotherapy
    Guo, Jinling
    Qin, Yanzhu
    Li, Caixia
    He, Juhua
    Zeng, Lijun
    Peng, Jing
    CANCER NURSING, 2025,
  • [46] Expression of Programmed Death-Ligand 1 and Programmed Death-1 in Patients with Extramammary Paget's Disease
    Goto, Hiroyuki
    Sugita, Kazunari
    Yamamoto, Osamu
    INDIAN JOURNAL OF DERMATOLOGY, 2021, 66 (02) : 169 - 173
  • [47] Programmed Death-1 and Programmed Death-Ligand 1 Expression Patterns in Pediatric Lymphoma
    Tamura, Akihiro
    Yoshida, Makiko
    Yamamoto, Nobuyuki
    Nino, Nanako
    Nakatani, Naoko
    Ichikawa, Takayuki
    Nakamura, Sayaka
    Saito, Atsuro
    Kozaki, Aiko
    Kishimoto, Kenji
    Ishida, Toshiaki
    Hasegawa, Daiichiro
    Kosaka, Yoshiyuki
    BLOOD, 2018, 132
  • [48] Vitiligo under anti-programmed cell death-1 therapy is associated with increased survival in melanoma patients
    Nardin, Charlee
    Jeand'heur, Anne
    Bouiller, Kevin
    Valnet-Rabier, Marie Blanche
    Dresco, Flora
    Castagna, Julie
    Mareschal, Adrien
    Carlet, Clementine
    Nerich, Virginie
    Limat, Samuel
    Puzenat, Eve
    Aubin, Francois
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 82 (03) : 770 - 772
  • [49] Programmed death-1 and programmed death ligand-1 blockade for advanced urothelial carcinoma
    Guo, Jhe-Cyuan
    Tsai, Yu-Chieh
    Pu, Yeong-Shiau
    UROLOGICAL SCIENCE, 2019, 30 (01) : 2 - 7
  • [50] Hair Repigmentation During Immunotherapy Treatment With an Anti-Programmed Cell Death 1 and Anti-Programmed Cell Death Ligand 1 Agent for Lung Cancer
    Rivera, Noelia
    Boada, Aram
    Isabel Bielsa, M.
    Teresa Fernandez-Figueras, M.
    Carcereny, Enric
    Teresa Moran, M.
    Ferrandiz, Carlos
    JAMA DERMATOLOGY, 2017, 153 (11) : 1162 - 1165
12345